Clearside Biomedical Inc. (CLSD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM

Clearside Biomedical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
13.63M 20.02M 13.89M 18.24M 35.35M 28.92M 28.8M 35.01M 41.42M 48.26M 53.38M 29.03M 34.37M 30.44M 25.22M 26.41M 26.15M
Short-Term Investments
n/a n/a 9.7M 11.12M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a 30K n/a 160K n/a n/a n/a n/a n/a
Other Long-Term Assets
30K 30K 30K 30K 30K 30K 30K 30K 30K 1.14M 160K n/a 160K 160K 160K 160K 260K
Receivables
1.54M 507K 788K n/a n/a 170K 882K 255K n/a n/a 123K 123K n/a 10M n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a 1.12M 542K n/a n/a 1.05M 439K n/a 921K n/a n/a n/a
Other Current Assets
798K 13K 13K 44K 193K 311K 14K 305K 386K 439K 311K 394K 339K 779K 119K 880K 142K
Total Current Assets
15.96M 21.27M 25.11M 29.77M 36.12M 30.12M 30.82M 36.11M 42.57M 48.26M 54.86M 29.99M 35.27M 42.14M 26.52M 27.65M 26.7M
Property-Plant & Equipment
3.67M 3.82M 4.02M 4.14M 4M 3.87M 3.58M 3.05M 2.1M 1.87M 663K 597K 625K 607K 695K 779K 862K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
3.7M 3.85M 4.05M 4.17M 4.03M 3.9M 3.6M 3.08M 2.13M 3.04M 823K 757K 785K 767K 855K 939K 1.12M
Total Assets
19.67M 25.13M 29.16M 33.93M 40.14M 34.02M 34.42M 39.19M 44.7M 51.3M 55.69M 30.75M 36.06M 42.9M 27.38M 28.59M 27.82M
Account Payables
1.91M 1.45M 2.36M 1.58M 1.36M 2.21M 1.87M 1.89M 1.59M 1.05M 1.74M 2.64M 1.4M 941K 776K 1.22M 2.34M
Deferred Revenue
n/a n/a n/a 225K 150K 75K n/a 355K 280K 205K 113K n/a 198K n/a 5M 5M 5M
Short-Term Debt
378K 375K 373K 370K n/a 364K 362K 359K n/a n/a 407K 395K 391K n/a 384K 380K 377K
Other Current Liabilities
2.72M 2.16M 1.39M 2.3M 3.48M 1.94M 1.94M 1.34M 571K 2.34M 1.29M 1.05M 1.26M n/a 1.47M 979K 1.71M
Total Current Liabilities
5.01M 4.79M 5.59M 5.87M 5.95M 6.81M 5.83M 5.27M 4.98M 5.78M 5.2M 5.39M 4.16M 4.64M 9.16M 8.8M 10.3M
Long-Term Debt
241K 51.77M 49.19M 46.73M 44.39M 41.99M n/a n/a n/a n/a 31.93M n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
60.33M 58.86M 57.95M 9.12M 11.04M 480K 40.71M 38.09M 36.14M 33.98M n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
60.57M 59.19M 58.36M 56.34M 56M 43.12M 41.43M 38.88M 37.01M 33.98M 31.93M 105K 200K 288K 374K 458K 539K
Total Liabilities
65.58M 63.98M 63.95M 62.22M 61.95M 49.93M 47.27M 44.16M 41.99M 40.7M 37.14M 5.5M 4.36M 4.93M 9.53M 9.25M 10.84M
Total Debt
619K 703K 785K 47.59M 45.33M 43M 1.09M 1.16M 1.22M 1.28M 407K 500K 591K 675K 758K 838K 916K
Common Stock
77K 77K 75K 74K 74K 63K 62K 62K 61K 61K 60K 60K 60K 60K 60K 59K 58K
Retained Earnings
-363.5M -355.27M -347.97M -340.28M -332.69M -320.92M -316.09M -306.82M -297.72M -288.44M -278.77M -270.95M -263.13M -255.49M -274.2M -269.31M -263.22M
Comprehensive Income
n/a n/a 5K -1K -0.00 n/a n/a n/a n/a n/a -0.00 -0.00 n/a n/a n/a n/a -822K
Shareholders Equity
-45.91M -38.85M -34.79M -28.29M -21.81M -15.91M -12.85M -4.97M 2.7M 10.61M 18.55M 25.25M 31.7M 37.98M 17.85M 19.34M 16.98M
Total Investments
n/a n/a 9.7M 11.12M n/a n/a n/a n/a n/a 30K n/a 160K n/a n/a n/a n/a n/a